KALEIDO BIOSCIENCES INC's ticker is KLDO and the CUSIP is 483347100. A total of 61 filers reported holding KALEIDO BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $10,543,000 | -31.0% | 6,389,660 | +0.0% | 0.00% | 0.0% |
| Q4 2021 | $15,270,000 | -56.2% | 6,389,152 | +0.0% | 0.00% | -66.7% |
| Q3 2021 | $34,871,000 | -26.5% | 6,386,629 | +0.1% | 0.00% | -25.0% |
| Q2 2021 | $47,451,000 | -8.0% | 6,377,797 | +0.1% | 0.00% | 0.0% |
| Q1 2021 | $51,597,000 | +53.6% | 6,370,018 | +72.5% | 0.00% | +33.3% |
| Q4 2020 | $33,602,000 | -3.7% | 3,692,559 | +17.2% | 0.00% | -25.0% |
| Q3 2020 | $34,884,000 | +72.9% | 3,151,259 | +16.1% | 0.00% | +100.0% |
| Q2 2020 | $20,170,000 | +44.1% | 2,714,722 | +19.3% | 0.00% | 0.0% |
| Q1 2020 | $13,997,000 | +33.6% | 2,276,007 | +9.1% | 0.00% | +100.0% |
| Q4 2019 | $10,476,000 | -29.2% | 2,086,907 | +6.2% | 0.00% | -50.0% |
| Q3 2019 | $14,801,000 | -32.4% | 1,965,624 | +2.1% | 0.00% | -33.3% |
| Q2 2019 | $21,895,000 | -12.9% | 1,925,007 | +6.4% | 0.00% | 0.0% |
| Q1 2019 | $25,143,000 | – | 1,809,083 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 19,575,710 | $158,562,000 | 2.54% |
| HARBOURVEST PARTNERS LLC | 1,833,832 | $14,854,000 | 1.99% |
| Trustees of Columbia University in the City of New York | 150,150 | $1,216,000 | 1.47% |
| Palo Alto Investors LP | 786,400 | $6,370,000 | 0.36% |
| Artal Group S.A. | 500,500 | $4,054,000 | 0.07% |
| EXANE DERIVATIVES | 21,333 | $172,790,000 | 0.05% |
| FEDERATED HERMES, INC. | 825,000 | $6,683,000 | 0.01% |
| Johnson Midwest Financial, LLC | 745 | $6,000 | 0.01% |
| FMR LLC | 6,370,018 | $51,597,000 | 0.00% |
| Cerity Partners LLC | 18,500 | $150,000 | 0.00% |